Silence Therapeutics Plc American Depository Share Company Profile
NASDAQ: SLNHealthcareBiotechnologyUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Silence Therapeutics Plc American Depository Share at a glance
Silence Therapeutics Plc American Depository Share (NASDAQ: SLN) is a Biotechnology company in the Healthcare sector headquartered in London, United Kingdom. Silence Therapeutics Plc American Depository Share is led by Mr. Iain Gladstone Ross B.Sc., BSc (Hons), C.DIR, CH.D and employs about 88 people. At a market capitalization of $591.7 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0001479615, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Silence Therapeutics Plc American Depository Share do?
Silence Therapeutics plc, a biotechnology company, engages in the discovery and development of novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes in hematology, cardiovascular, and rare diseases. The company develops Divesiran (SLN124), which is in Phase 2 development for polycythemia vera, and SLN548 for complement-mediated renal diseases. It also develops Zerlasiran (SLN360) for cardiovascular disease associated with elevated lipoprotein(a); SLN312 for dyslipidemia; SLN365 for hypercholesterolemia; and SLN098 for obesity. The company was formerly known as SR Pharma plc and changed its name to Silence Therapeutics plc in May 2007. Silence Therapeutics plc was incorporated in 1994 and is headquartered in London, United Kingdom.
Business description based on the company's public filings.
Company information
- Legal name
- Silence Therapeutics Plc American Depository Share
- Ticker
- NASDAQ: SLN
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Iain Gladstone Ross B.Sc., BSc (Hons), C.DIR, CH.D
- Employees
- 88
- Headquarters
- 12 Hammersmith Grove, London, United Kingdom
- Phone
- 44 20 3457 6900
- Website
- silence-therapeutics.com
- Market cap
- $591.71M
- SEC CIK
- 0001479615
- Latest annual report
- 10-K · Mar 5, 2026
Companies similar to Silence Therapeutics Plc American Depository Share
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| PHATPhathom Pharmaceuticals Inc. | 7.13 | +4.70% | $576.82M | vs SLN |
| RGNXREGENXBIO Inc. | 8.09 | +6.52% | $534.05M | vs SLN |
| NGNENeurogene Inc. | 26.50 | +2.44% | $530.30M | vs SLN |
| NVCTNuvectis Pharma Inc. | 20.13 | -0.79% | $657.12M | vs SLN |
| OABIOmniAb Inc. | 4.66 | +2.19% | $677.52M | vs SLN |
| VSTMVerastem Inc. | 8.11 | -1.88% | $734.47M | vs SLN |
| RZLTRezolute Inc. | 4.64 | +5.94% | $448.79M | vs SLN |
| CADLCandel Therapeutics Inc. | 9.66 | -1.63% | $739.17M | vs SLN |